Announcements Trials

Browse Landscape

Status

Unknown 3 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Recurrence 1 Radiation Injuries 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Cholangiocarcinoma 1 Cervical Cancer Susceptible Population Classification 1 Biliary Tract Neoplasms 1

Interventions

pembrolizumab 38 Blood Specimen Collection 38 Bevacizumab 22 Surveys and Questionnaires 18 Standard of Care 18 Radiotherapy 17 Exercise 17 Carboplatin 17 Nivolumab 15 atezolizumab 14 Paclitaxel 14 Cisplatin 14 Drug Therapy 13 Fluorouracil 12 Cyclophosphamide 12 Cetuximab 11 Trastuzumab 10 Pemetrexed 10 Leucovorin 10 Docetaxel 10 Dexamethasone 10 Oxaliplatin 9 Biopsy 9 pertuzumab 8 olaparib 8 Temozolomide 8 Panitumumab 8 Observation 8 Irinotecan 8 abemaciclib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasms × Base Sequence × Clear all

NCT05504772 2024-07-17

ZERO2

Australian & New Zealand Children's Haematology/Oncology Group

Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡